Xhosa
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message
Kwi-intanethi
6503fd01jm
isilayidi1
isilayidi1
isilayidi1
01020304
01
Disemba, 26-23

Imizuzu ye-3 yokuqonda i-NAD + kunye ne-NMN, iintandokazi ezicetyiswayo

Inxalenye yesibini Ubudlelwane phakathi kwe-NAD+ kunye nesifo: Izilonda ezibangelwa kukungaqhelekanga kwe-NAD+ imetabolism 01.NAD+ kunye nosulelo Kuyaziwa ngoku ukuba ukosuleleka ziintsholongwane ezininzi kuya kubangela ...
ENTSHA KWELI IXESHA 659cbc9fiy

YETHU
IMVELISO

Funda ngokugqithisileyo
527sb8
01
Disemba, 26-23

Imizuzu ye-3 yokuqonda i-NAD + kunye ne-NMN, iintandokazi ezicetyiswayo

Inxalenye yesibini Ubudlelwane phakathi kwe-NAD+ kunye nesifo: Izilonda ezibangelwa kukungaqhelekanga kwe-NAD+ imetabolism 01.NAD+ kunye nosulelo Kuyaziwa ngoku ukuba ukosuleleka ziintsholongwane ezininzi kuya kubangela ...
ENTSHA KWELI IXESHA 659cbc9pwi
HPLC24qx
01
Disemba, 26-23

Imizuzu ye-3 yokuqonda i-NAD + kunye ne-NMN, iintandokazi ezicetyiswayo

Inxalenye yesibini Ubudlelwane phakathi kwe-NAD+ kunye nesifo: Izilonda ezibangelwa kukungaqhelekanga kwe-NAD+ imetabolism 01.NAD+ kunye nosulelo Kuyaziwa ngoku ukuba ukosuleleka ziintsholongwane ezininzi kuya kubangela ...
ENTSHA KWELI IXESHA 659cbc97q5
52384v
01
Disemba, 26-23

Imizuzu ye-3 yokuqonda i-NAD + kunye ne-NMN, iintandokazi ezicetyiswayo

Inxalenye yesibini Ubudlelwane phakathi kwe-NAD+ kunye nesifo: Izilonda ezibangelwa kukungaqhelekanga kwe-NAD+ imetabolism 01.NAD+ kunye nosulelo Kuyaziwa ngoku ukuba ukosuleleka ziintsholongwane ezininzi kuya kubangela ...
ENTSHA KWELI IXESHA 659cbc946j
260 hayi
01
Disemba, 26-23

Imizuzu ye-3 yokuqonda i-NAD + kunye ne-NMN, iintandokazi ezicetyiswayo

Inxalenye yesibini Ubudlelwane phakathi kwe-NAD+ kunye nesifo: Izilonda ezibangelwa kukungaqhelekanga kwe-NAD+ imetabolism 01.NAD+ kunye nosulelo Kuyaziwa ngoku ukuba ukosuleleka ziintsholongwane ezininzi kuya kubangela ...
ENTSHA KWELI IXESHA 659cbc94xq

Iindaba zeShishini

Funda ngokugqithisileyo
Usuku lweSifo seswekile lweHlabathi: Ukuthethelela ukuQaphela kunye noThintelo Usuku lweSifo seswekile lweHlabathi: Ukuthethelela ukuQaphela kunye noThintelo
01

Usuku lweSifo seswekile lweHlabathi: Ukuthethelela ukuQaphela kunye noThintelo

2024-11-14
Funda ngokugqithisileyo
I-High-sensitivity troponin ye-cardiac I (Hs-cTnI): isalathisi esitsha sempilo yentliziyo I-High-sensitivity troponin ye-cardiac I (Hs-cTnI): isalathisi esitsha sempilo yentliziyo
02

I-High-sensitivity troponin ye-cardiac I (Hs-cTnI): isalathisi esitsha sempilo yentliziyo

2024-11-07
Funda ngokugqithisileyo
Uphononongo lutyhila iMpembelelo yeMpilo ye-Vitamin B12 Uphononongo lutyhila iMpembelelo yeMpilo ye-Vitamin B12
03

Uphononongo lutyhila iMpembelelo yeMpilo ye-Vitamin B12

2024-09-23
I-AEHEALTH LIMITED inike ingxelo ngokubaluleka kwe-vitamin B12 ekugcineni impilo yonke. Inkampani ibonise umngcipheko wokunqongophala kwe-vitamin B12, enokuthi ichaphazele inkqubo ye-nervous kwaye ibangele ukukhathala, ubuthathaka kunye ne-anemia. I-AEHEALTH LIMITED ibethelele imfuneko yokuba umntu ngamnye awazi amanqanaba evithamini B12 aze atye imithombo yevithamini efana nenyama, intlanzi kunye neemveliso zobisi. Inkampani iphinde yagxininisa ukubaluleka kokuhlolwa rhoqo kunye nokubonisana nabasebenzi bezempilo ukuba babeke iliso kunye nokujongana nazo naziphi na iintsilelo ezinokubakho. Ezi ndaba ziza njengesikhumbuzo sokuba abantu babeke phambili ukuthatha iivithamini zabo kwimpilo yabo yonke kunye nokuphila kakuhle.
Funda ngokugqithisileyo
I-Laffinite II iPhumelela iSiqinisekiso se-NGSP I-Laffinite II iPhumelela iSiqinisekiso se-NGSP
04

I-Laffinite II iPhumelela iSiqinisekiso se-NGSP

2024-06-05
I-AEHEALTH LIMITED yazisa ukuba indlela yayo yeLaffinite II HbA1c ifumene isatifikethi esivela kwi-NGSP, ebonisa ukuqhubela phambili okukhulu kwi-diagnostics yonyango. Isiqinisekiso siqinisa i-Laffinite II analyzer njengesisombululo se-state-of-art sokuzihlukanisa ngokuzenzekelayo kwe-HbA1c. Le mpumelelo linyathelo elibalulekileyo kwinkampani kwaye igxininisa umgangatho ophezulu kunye nokuthembeka kobuchwepheshe bayo bokuxilonga. Ukuphuhliswa komhlaba kunamandla okuba nefuthe kakhulu kwintsimi yezonyango kunye nokuphucula ukunakekelwa kwesigulane. Ukuzibophelela kwe-AEHEALTH LIMITED ekwenzeni izinto ezintsha kunye nokugqwesa kuye kwaqatshelwa ngesi satifikethi, sibeka inkampani njengenkokeli kuxilongo lwezonyango oluphezulu.
Funda ngokugqithisileyo
Uphononongo olutsha luveza iimvavanyo ezine ezibalulekileyo kwizifo zamathambo Uphononongo olutsha luveza iimvavanyo ezine ezibalulekileyo kwizifo zamathambo
05

Uphononongo olutsha luveza iimvavanyo ezine ezibalulekileyo kwizifo zamathambo

2024-06-01

I-arthritis ye-Rheumatoid (RA) sisifo esingapheliyo sokuvuvukala esichaphazela amalunga, kubangela intlungu, ukuvuvukala, ukuqina, kunye nokulahlekelwa ngumsebenzi. Inokuchaphazela namanye amalungu. UMbutho wezeMpilo weHlabathi (i-WHO) uqikelela ukuba malunga ne-1% yabemi behlabathi ichatshazelwa yiRA, kwaye abasetyhini bachaphazeleka ngokuphindwe kathathu kunamadoda. Esi sifo singenzeka nanini na ubudala, kodwa ngokuqhelekileyo kwenzeka emva kweminyaka engama-40 nangaphambi kweminyaka engama-60. Ukuba ayilawulwa kakuhle, i-rheumatoid arthritis ingabangela ukukhubazeka okukhulu kwaye inciphise ixesha lokuphila.

Funda ngokugqithisileyo
Medlab Middle East 2023, isiphelo esigqibeleleyo! Medlab Middle East 2023, isiphelo esigqibeleleyo!
06

Medlab Middle East 2023, isiphelo esigqibeleleyo!

2024-02-09
Funda ngokugqithisileyo
Medlab Middle East 2024, Dubai World Trade Centre Medlab Middle East 2024, Dubai World Trade Centre
07

Medlab Middle East 2024, Dubai World Trade Centre

2023-12-27
Funda ngokugqithisileyo
AACC 2023 -- IZiko leNgqungquthela laseAnaheim, eCalifornia, eMelika AACC 2023 -- IZiko leNgqungquthela laseAnaheim, eCalifornia, eMelika
08

AACC 2023 -- IZiko leNgqungquthela laseAnaheim, eCalifornia, eMelika

2023-06-06
Funda ngokugqithisileyo
010203

Malunga neNkampani

I-Aehealth iphuhlisa ngokukhawuleza i-high-tech In-Vitro Diagnostic inkampani, kunye neqela elijolise kwindawo yokunakekelwa kwempilo yabantu iminyaka.
Sidibanisa iqela lethu elizinikeleyo kunye neqela lobuchwephesha loPhando kunye noPhuhliso, ukuVelisa, ukuThengisa kunye nokuThengisa, kunye neNkonzo ukuze siqonde umgangatho ophezulu wemveliso kunye nokubekwa kweeMveliso ze-In-Vitro Diagnostic, iiMveliso zoVavanyo oluKhawulezayo, iimveliso zokhathalelo lwasekhaya njl.